About: Ibrahim Yakoub-Agha

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Ibrahim Yakoub-Agha Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

researcher, ORCID id # 0000-0003-4524-8782

Attributes	Values
rdf:type	Item
description	forskare (sv) 연구원 (ko) araştırmacı (tr) эрдэмтэн (mn) वैज्ञानिक (hi) изилдөөчү (ky) onderzoeker (nl) researcher, ORCID id # 0000-0003-4524-8782 (en)
rdfs:label	Ibrahim Yakoub-Agha (en) Ibrahim Yakoub-Agha (es) Ibrahim Yakoub-Agha (nl) Ibrahim Yakoub-Agha (ast)
skos:prefLabel	Ibrahim Yakoub-Agha (en) Ibrahim Yakoub-Agha (es) Ibrahim Yakoub-Agha (nl) Ibrahim Yakoub-Agha (ast)
name	Ibrahim Yakoub-Agha (en) Ibrahim Yakoub-Agha (es) Ibrahim Yakoub-Agha (nl) Ibrahim Yakoub-Agha (ast)
instance of	wds:Q58191171-5416DC66-2EF7-4ADE-A861-77C3D588A647
instance of	Homo sapiens
occupation	wds:Q58191171-0676C952-947A-49E6-B4F4-439AF6F5FD97
employer	wds:Q58191171-9B859D27-A543-47CE-B2C5-BB175FF4BC45
sex or gender	wds:Q58191171-356554DC-D7E4-4252-B630-11BAB01109DF
ISNI	wds:Q58191171-E86CC52B-B200-4C00-8D4A-165BF334F8FA
VIAF ID	wds:Q58191171-CDC5AA69-2D6E-4B40-9784-E8711074EA2E
GND ID	wds:Q58191171-24eb1bb3-6dac-4e17-bac6-c4ed206eb9e5
IdRef ID	wds:Q58191171-F9C31ADA-037F-40C1-ABAF-2A1BA390011A
date of birth	wds:Q58191171-2FFC1BC8-60A7-4895-9156-C267BF703380
National Library of Israel J9U ID	wds:Q58191171-B26A16B7-231B-483A-91C5-4E78F9C1E55F
VIAF ID	http://viaf.org/viaf/197043068
GND ID	https://d-nb.info/gnd/1017074054
IdRef ID	http://www.idref.fr/069672504/id
occupation	researcher
employer	Lille university hospital - Centre hospitalier régional universitaire de Lille
sex or gender	male
ISNI	0000000357390479
VIAF ID	197043068
GND ID	1017074054
IdRef ID	069672504
date of birth	1962-01-01 00:00:00Z (xsd:dateTime)
National Library of Israel J9U ID	987012501148005171
ORCID iD	wds:Q58191171-F7E580F5-2D2E-408E-8CF1-456D1445F6A0
ORCID iD	https://orcid.org/0000-0003-4524-8782
ORCID iD	0000-0003-4524-8782
ResearcherID	wds:Q58191171-414E566D-4122-4904-9A1B-4717948428A5
ResearcherID	R-7872-2018
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q58191171
is author of	Reduced-intensity conditioning before allogeneic hematopoietic stem cell transplantation in patients over 60 years: a report from the SFGM-TC Thalidomide in patients with advanced multiple myeloma: a study of 83 patients--report of the Intergroupe Francophone du Myélome (IFM). Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation. Treatment strategies in relapsed and refractory multiple myeloma: a focus on drug sequencing and 'retreatment' approaches in the era of novel agents. Immunosuppressive drugs and fertility Comparison of outcomes after single or double cord blood transplantation in adults with acute leukemia using different types of myeloablative conditioning regimen, a retrospective study on behalf of Eurocord and the Acute Leukemia Working Party of E Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial Plasma levels of IL-7 and IL-15 after reduced intensity conditioned allo-SCT and relationship to acute GVHD Allogeneic Bone Marrow Transplantation for Therapy-Related Myelodysplastic Syndrome and Acute Myeloid Leukemia: A Long-Term Study of 70 Patients—Report of the French Society of Bone Marrow Transplantation Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives-a position statement from the European Society for Blood and Marrow Transplantation (EBMT) Diagnosis of invasive aspergillosis using bronchoalveolar lavage in haematology patients: influence of bronchoalveolar lavage human DNA content on real-time PCR performance. Activity of fludarabine in previously treated Waldenström's macroglobulinemia: a report of 71 cases. Groupe Coopératif Macroglobulinémie. Malassezia furfur septicaemia in a child with leukaemia Plasma levels of IL-7 and IL-15 in the first month after myeloablative BMT are predictive biomarkers of both acute GVHD and relapse Upfront allogeneic stem cell transplantation after reduced-intensity/nonmyeloablative conditioning for patients with myelodysplastic syndrome: a study by the Société Française de Greffe de Moelle et de Thérapie Cellulaire. Primary follicular lymphoma of the gastrointestinal tract: a study of 25 cases and a literature review. Peripheral neuropathy and new treatments for multiple myeloma: background and practical recommendations. Low nonrelapse mortality and prolonged long-term survival after reduced-intensity allogeneic stem cell transplantation for relapsed or refractory diffuse large B cell lymphoma: report of the Société Française de Greffe de Moelle et de Thérapie Cellu Reduced-intensity conditioning allogeneic stem cell transplantation for relapsed/refractory mantle cell lymphoma: a multicenter experience. Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myélome. Lenalidomide as salvage treatment for multiple myeloma relapsing after allogeneic hematopoietic stem cell transplantation: a report from the French Society of Bone Marrow and Cellular Therapy Clinical activity of azacitidine in patients who relapse after allogeneic stem cell transplantation for acute myeloid leukemia. Unrelated cord blood transplantation for adult patients with acute myeloid leukemia: higher incidence of acute graft-versus-host disease and lower survival in male patients transplanted with female unrelated cord blood--a report from Eurocord, the A Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy: a prospective study from the F Graft-versus-lymphoma effect for aggressive T-cell lymphomas in adults: a study by the Société Francaise de Greffe de Moëlle et de Thérapie Cellulaire. Prospective comparison of autologous stem cell transplantation followed by dose-reduced allograft (IFM99-03 trial) with tandem autologous stem cell transplantation (IFM99-04 trial) in high-risk de novo multiple myeloma Cost-effectiveness and clinical outcomes of double versus single cord blood transplantation in adults with acute leukemia in France Enteral feeding and early outcomes of patients undergoing allogeneic stem cell transplantation following myeloablative conditioning Thalidomide salvage therapy following allogeneic stem cell transplantation for multiple myeloma: a retrospective study from the Intergroupe Francophone du Myélome (IFM) and the Société Française de Greffe de Moelle et Thérapie Cellulaire (SFGM-TC). Tandem autologous stem cell transplantation in high-risk de novo multiple myeloma: final results of the prospective and randomized IFM 99-04 protocol Better outcome of patients undergoing enteral tube feeding after myeloablative conditioning for allogeneic stem cell transplantation Outcomes of adults with active or progressive hematological malignancies at the time of allo-SCT: a survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). Impact of minimal residual disease on outcomes after umbilical cord blood transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia: an analysis on behalf of Eurocord, Cord Blood Committee and the Acute Leukaemia working pa Allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia in remission: comparison of intravenous busulfan plus cyclophosphamide (Cy) versus total-body irradiation plus Cy as conditioning regimen--a report from the acute leukemia Efficacy of imatinib mesylate in the treatment of refractory sclerodermatous chronic GVHD. Efficacy of thalidomide in a child with histiocytic sarcoma following allogeneic bone marrow transplantation for T-ALL. Quantification by magnetic resonance imaging and liver consequences of post-transfusional iron overload alone in long term survivors after allogeneic hematopoietic stem cell transplantation (HSCT) Early human herpesvirus type 6 reactivation after allogeneic stem cell transplantation: a large-scale clinical study. Naïve subset develops the most important alloreactive response among human CD4+ T lymphocytes in human leukocyte antigen-identical related setting. Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia Matching for the nonconventional MHC-I MICA gene significantly reduces the incidence of acute and chronic GVHD. Impact of genetic abnormalities after allogeneic stem cell transplantation in multiple myeloma: a report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire Heterogeneity of t(4;14) in multiple myeloma. Long-term follow-up of 100 cases treated with tandem transplantation in IFM99 trials Long-term follow-up results of IFM99-03 and IFM99-04 trials comparing nonmyeloablative allotransplantation with autologous transplantation in high-risk de novo multiple myeloma Enteral nutrition: a first option for nutritional support of children following allo-SCT? Unmanipulated haploidentical versus matched unrelated donor allogeneic stem cell transplantation in adult patients with acute myelogenous leukemia in first remission: a retrospective pair-matched comparative study of the Beijing approach with the EB Hematopoietic stem-cell transplantation for advanced systemic mastocytosis Management of Myelodysplastic Syndrome Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation: A Study by the French Society of Bone Marrow Transplantation and Cell Therapies. Unrelated alternative donor transplantation for severe acquired aplastic anemia: a study from the French Society of Bone Marrow Transplantation and Cell Therapies and the EBMT Severe Aplastic Anemia Working Party Are hypomethylating agents replacing induction-type chemotherapy before allogeneic stem cell transplantation in patients with myelodysplastic syndrome?

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software